|
|
Aaron Industries
|
|
|
Aaron Industries Limited has informed the Exchange regarding 'Update under Regulation 30 of the SEBI (LODR) Regulations, 2015'.
|
|
Angel Fibers
|
|
|
There is no any material development which falls under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
|
|
Ansal Prop. & Infra
|
|
|
This is in furtherance to our letter dated the 20th December, 2020, enclosing the Notice and the Explanatory Statement, for seeking consent of the Members of theCompany through Postal Ballot by way of remote e-voting process for approving the following resolutions: 1)Issue and allotment up to an aggregate of 5,00,10,000 nos. of Warrants, convertible into equivalent nos. of Equity shares (i.e. one fully paid up Equity share upon conversion of every one Warrant held) of a face value of Rs. 5/- (Rupees Five) each of the Company ('Warrants'), at an exercise price of Rs 7/- (including a premium of Rs 2/-) per Equity share ('Exercise Price'),to specified Non-Promoters (Public), by way of passing a Special Resolution; 2)Appointment of Shri Dinesh Chander Gupta (DIN: 00840629) as a Director of the Company, by way of passing an Ordinary Resolution 3)Appointment of Shri Dinesh Chander Gupta (DIN: 00840629) as a Whole Time Director and CEO of the Company, by way of passing an Ordinary Resolution.
|
|
Asian Petroproducts
|
|
|
Dear Sir / Ma'am, Further to our letter dated 18th January, 2021, vide letter no. 117/fy20-21, the following may be noted:- 1. The Notice of the Postal Ballot dated January 18, 2021 was read by the Directors and taken as approved. 2. The board has fixed January 15, 2021 as the cut-off date for the purpose of dispatch of postal ballot notice along with the details of e-voting to the shareholders. 3. The Relevant Date for the proposed Preferential Allotment is 19th January, 2021. 4. The Board has appointed Mr. Devesh Pathak as a Scrutinizer for the purpose of the same. Kindly take the same on your records.
|
|
Balaxi Pharma.
|
|
|
BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended December 31, 2020.
|
|
Balaxi Pharma.
|
|
|
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Board meeting held on January 19, 2021.
|
|
Balaxi Pharma.
|
|
|
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated January 19, 2021, titled "Balaxi Pharmaceuticals reports Revenue of INR 1,784 million for 9M FY21".
|
|
Beekay Niryat
|
|
|
We hereby inform that the Board of Directors of the Company in its meeting held on 19th January, 2021 have accepted resignation dated 16th December, 2020 received from Ms. Jaishree Motwani (earlier Ms. Jaishree Datwani) (holding Membership No. A37429) from the post of Company Secretary & Compliance Officer of the Company due to personal reasons with effect from 19th January, 2021 (From the closure of Business hours).
|
|
Beekay Niryat
|
|
|
We hereby inform that Mr. Bhavesh Surolia (M. No. A64329) a qualified member of Institute of Company Secretaries of India has been appointed for the post of Company Secretary & Compliance Officer (Key Managerial Personnel) of the Company with effect from 20th January, 2021 and his appointment has been confirmed in the board meeting held on 19th January, 2021.
|
|
Bhel
|
|
|
BHEL wins Institute of Chartered Accountants of India's National Award 2019-20 for Excellence in Financial Reporting
|
|
|
|
|
|
|
|